Citations (108)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (12)
Gian Paolo Caviglia, Stefano Pantaleoni, Giovanni Antonio Touscoz, Alessandro Adriani, Chiara Rosso, Antonina Smedile, Rinaldo Pellicano, Marco Astegiano & Francesca Bresso. (2014) Fecal calprotectin is an effective diagnostic tool that differentiates inflammatory from functional intestinal disorders. Scandinavian Journal of Gastroenterology 49:12, pages 1419-1424.
Read now
Read now
Tonje Oord & Nete Hornung. (2014) Fecal calprotectin in healthy children. Scandinavian Journal of Clinical and Laboratory Investigation 74:3, pages 254-258.
Read now
Read now
Andrea Hille, Margret Rave-Fränk, Hans Christiansen, Markus K. A. Herrmann, Tereza Kertesz, Robert M. Hermann, Hendrik A. Wolff, Markus Schirmer, Clemens F. Hess & Giuliano Ramadori. (2009) Faecal calprotectin and lactoferrin values during irradiation of prostate cancer correlate with chronic radiation proctitis: Results of a prospective study. Scandinavian Journal of Gastroenterology 44:8, pages 939-946.
Read now
Read now
Claudia I. Reinders, Daisy Jonkers, Emmelie Å. Jansson, Reinhold W. Stockbrügger, Ellen E. Stobberingh, Per M. Hellström & Jon O. Lundberg. (2007) Rectal nitric oxide and fecal calprotectin in inflammatory bowel disease. Scandinavian Journal of Gastroenterology 42:10, pages 1151-1157.
Read now
Read now
Njaal Stray & Ragnar Weberg. (2006) A prospective study of same day bi-directional endoscopy in the evaluation of patients with occult gastrointestinal bleeding. Scandinavian Journal of Gastroenterology 41:7, pages 844-850.
Read now
Read now
J. Vironen, S. Kellokumpu, L. C. Andersson & I. Kellokumpu. (2004) Comparison of a peanut agglutinin test and an immunochemical faecal occult blood test in detecting colorectal neoplasia in symptomatic patients. Scandinavian Journal of Clinical and Laboratory Investigation 64:2, pages 140-145.
Read now
Read now
B. Johne, O. Kronborg, H. I. Tøn, J. Kristinsson, P. Fuglerud. (2001) A New Fecal Calprotectin Test for Colorectal Neoplasia: Clinical Results and Comparison with Previous Method. Scandinavian Journal of Gastroenterology 36:3, pages 291-296.
Read now
Read now
J. Kristinsson, Chr. Armbruster, M. Ugstad, S. Kriwanek, K. Nygaard, H. Tøn, P. Fuglerud. (2001) Fecal Excretion of Calprotectin in Colorectal Cancer Relationship to Tumor Characteristics. Scandinavian Journal of Gastroenterology 36:2, pages 202-207.
Read now
Read now
J. Kristinsson. (1999) Granulocyte Marker Protein Is Increased in Stools from Rats with Azoxymethane-Induced Colon Cancer. Scandinavian Journal of Gastroenterology 34:12, pages 1216-1223.
Read now
Read now
S. Bülow & O. Kronborg. (1996) Prophylaxis against Colorectal Cancer. Scandinavian Journal of Gastroenterology 31:sup216, pages 160-168.
Read now
Read now
T. R. Meling, L. Aabakken, A. Røseth & M. Osnes. (1996) Faecal Calprotectin Shedding after Short-Term Treatment with Non-Steroidal Anti-Inflammatory Drugs. Scandinavian Journal of Gastroenterology 31:4, pages 339-344.
Read now
Read now
J. A. Gilbert, D. A. Ahlquist, D. W. Mahoney, A. R. Zinsmeister, J. Rubin & R. D. Ellefson. (1996) Fecal Marker Variability in Colorectal Cancer: Calprotectin versus Hemoglobin. Scandinavian Journal of Gastroenterology 31:10, pages 1001-1005.
Read now
Read now
Articles from other publishers (96)
Mehrnaz Nouri, Björn Weström & Shahram Lavasani. (2023) Elevated Fecal Calprotectin Accompanied by Intestinal Neutrophil Infiltration and Goblet Cell Hyperplasia in a Murine Model of Multiple Sclerosis. International Journal of Molecular Sciences 24:20, pages 15367.
Crossref
Crossref
Raheleh Heydari, Sara Fayazzadeh, Shabnam Shahrokh, Faezeh Shekari, Faraneh Farsad & Anna Meyfour. (2023) Plasma Extracellular Vesicle LncRNA H19 as a Potential Diagnostic Biomarker for Inflammatory Bowel Diseases. Inflammatory Bowel Diseases.
Crossref
Crossref
Sabrina Cenni, Marianna Casertano, Marco Trani, Daniela Pacella, Massimo Martinelli, Annamaria Staiano, Erasmo Miele & Caterina Strisciuglio. (2023) The use of calgranulin-C (S100A12) and fecal zonulin as possible non-invasive markers in children with inflammatory bowel disease: a clinical study. European Journal of Pediatrics 182:3, pages 1299-1308.
Crossref
Crossref
Nathalie Blad, Richard Palmqvist & Pontus Karling. (2022) Pre-diagnostic faecal calprotectin levels in patients with colorectal cancer: a retrospective study. BMC Cancer 22:1.
Crossref
Crossref
Fiona A. Ross, James H. Park, David Mansouri, Emilie Combet, Paul G. Horgan, Donald C. McMillan & Campbell S. D. Roxburgh. (2022) The role of faecal calprotectin in diagnosis and staging of colorectal neoplasia: a systematic review and meta-analysis. BMC Gastroenterology 22:1.
Crossref
Crossref
Rebecca J. Birch, Nicholas Burr, Venkataraman Subramanian, Jim P. Tiernan, Mark A. Hull, Paul Finan, Azmina Rose, Matthew Rutter, Roland Valori, Amy Downing & Eva J.A. Morris. (2022) Inflammatory Bowel Disease-Associated Colorectal Cancer Epidemiology and Outcomes: An English Population-Based Study. American Journal of Gastroenterology 117:11, pages 1858-1870.
Crossref
Crossref
Reza Ranjbar, Mohamad Ghasemian, Mahmood Maniati, Seyyed Hossein Khatami, Navid Jamali & Mortaza Taheri-Anganeh. (2022) Gastrointestinal disorder biomarkers. Clinica Chimica Acta 530, pages 13-26.
Crossref
Crossref
Atefeh Nasir Kansestani, Mohammad Erfan Zare, Qingchao Tong & Jun Zhang. (2022) Comparison of faecal protein biomarkers' diagnostic accuracy for colorectal advanced neoplasms: a systematic review and meta-analysis. Scientific Reports 12:1.
Crossref
Crossref
Jacqueline I. Keenan & Frank A. Frizelle. (2022) Biomarkers to Detect Early-Stage Colorectal Cancer. Biomedicines 10:2, pages 255.
Crossref
Crossref
Nilesh M. Mahajan, Alap Chaudhari, Sachin More & Purushottam Gangane. 2022. Photophysics and Nanophysics in Therapeutics. Photophysics and Nanophysics in Therapeutics
251
268
.
Gujjarlapudi Deepika, Namburu Veeraiah, Syed Hassan Naveed & D. Nageshwar Reddy. (2021) Fecal Calprotectin as early predictor for screening and relapse in pediatric chronic diarrhea in India. IP International Journal of Medical Paediatrics and Oncology 7:4, pages 178-184.
Crossref
Crossref
Willemijn de KlaverPieter H.A. WisseFrancine van Wifferen, Linda J.W. BoschConnie R. Jimenez, René W.M. van der HulstRemond J.A. Fijneman, Ernst J. Kuipers, Marjolein J.E. Greuter, Beatriz Carvalho, Manon C.W. Spaander, Evelien DekkerVeerle M.H. Coupé, Meike de Wit & Gerrit A. Meijer. (2021) Clinical Validation of a Multitarget Fecal Immunochemical Test for Colorectal Cancer Screening. Annals of Internal Medicine 174:9, pages 1224-1231.
Crossref
Crossref
Yee Man Kan, Sin Yan Chu & Ching Kong Loo. (2021) Diagnostic accuracy of fecal calprotectin in predicting significant gastrointestinal diseases. JGH Open 5:6, pages 647-652.
Crossref
Crossref
Carmen Ribes Koninckx, Ester Donat, Marc A. Benninga, Ilse J. Broekaert, Frederic Gottrand, Kaija-Leena Kolho, Paolo Lionetti, Erasmo Miele, Rok Orel, Alexandra Papadopoulou, Corina Pienar, Michela G. Schäppi, Michael Wilschanski & Nikhil Thapar. (2021) The Use of Fecal Calprotectin Testing in Paediatric Disorders: A Position Paper of the European Society for Paediatric Gastroenterology and Nutrition Gastroenterology Committee. Journal of Pediatric Gastroenterology & Nutrition 72:4, pages 617-640.
Crossref
Crossref
Rayna Shentova-Eneva & Tsvetelina Velikova. (2020) Laboratory Assessment of Disease Activity in Pediatric Patients with Inflammatory Bowel Disease: What’s New?. Gastroenterology Insights 11:2, pages 58-71.
Crossref
Crossref
Zong-Ran Chen & Gang Liu. (2019) Fecal calprotectin and colorectal cancer. World Chinese Journal of Digestology 27:23, pages 1436-1440.
Crossref
Crossref
Adi Lahat, Daniela Necula, Miri Yavzori, Orit Picard, Sharon Halperin, Rami Eliakim & Shomron Ben-Horin. (2019) Prolonged Recurrent Abdominal Pain is Associated With Ongoing Underlying Mucosal Inflammation in Patients who had an Episode of Acute Complicated Diverticulitis. Journal of Clinical Gastroenterology 53:5, pages e178-e185.
Crossref
Crossref
Yusuf Sahin, Ugur YucetasHuseyin Aytaç AtesErkan ErkanEsma YucetasMustafa Zafer TemizMahmut Gokhan ToktasMustafa KadihasanogluBirsen Cigdem Topkaya. (2019) Improving the diagnosis of high grade and stage bladder cancer by detecting increased urinary calprotectin expression in tumor tissue and tumor-associated inflammatory response. Investigative and Clinical Urology 60:5, pages 343.
Crossref
Crossref
Aryamitra Banerjee & Ramesh C. Gupta. 2019. Biomarkers in Toxicology. Biomarkers in Toxicology
277
285
.
Iftikhar Ahmed, Zafar Niaz, Frederick Ewbank, Danyal Akarca, Richard Felwick & Manuele Furnari. (2018) Sniffing out causes of gastrointestinal disorders: a review of volatile metabolomic biomarkers. Biomarkers in Medicine 12:10, pages 1139-1148.
Crossref
Crossref
Stephan R Vavricka, Henriette Heinrich, Simon Buetikofer, Flavia Breitenmoser, Emanuel Burri, Xiaoye Schneider-Yin, Jasmin Barman-Aksoezen, Luc Biedermann, Michael Scharl, Jonas Zeitz, Gerhard Rogler, Benjamin Misselwitz & Matthias Sauter. (2018) The Vampire Study: Significant elevation of faecal calprotectin in healthy volunteers after 300 ml blood ingestion mimicking upper gastrointestinal bleeding. United European Gastroenterology Journal 6:7, pages 1007-1014.
Crossref
Crossref
Romy M. Heilmann, Nora Berghoff, Joanne Mansell, Niels Grützner, Nolie K. Parnell, Corinne Gurtner, Jan S. Suchodolski & Jörg M. Steiner. (2018) Association of fecal calprotectin concentrations with disease severity, response to treatment, and other biomarkers in dogs with chronic inflammatory enteropathies. Journal of Veterinary Internal Medicine 32:2, pages 679-692.
Crossref
Crossref
Ruth M. Ayling & Klaartje Kok. 2018.
161
190
.
María Roca, Ana Rodriguez Varela, Ester Donat, Francisco Cano, David Hervas, Ana Armisen, Maria J. Vaya, Anders Sjölander & Carmen Ribes-Koninckx. (2017) Fecal Calprotectin and Eosinophil-derived Neurotoxin in Healthy Children Between 0 and 12 Years. Journal of Pediatric Gastroenterology & Nutrition 65:4, pages 394-398.
Crossref
Crossref
Jack L. Arbiser, Ron Nowak, Kellie Michaels, Yuliya Skabytska, Tilo Biedermann, Monica J. Lewis, Michael Y. Bonner, Shikha Rao, Linda C. Gilbert, Nabiha Yusuf, Isabella Karlsson, Yi Fritz & Nicole L. Ward. (2017) Evidence for biochemical barrier restoration: Topical solenopsin analogs improve inflammation and acanthosis in the KC-Tie2 mouse model of psoriasis. Scientific Reports 7:1.
Crossref
Crossref
Marianthi Chatzikonstantinou, Panagiotis Konstantopoulos, Spyros Stergiopoulos, Konstantinos Kontzoglou, Christos Verikokos, Despina Perrea & Dimitris Dimitroulis. (2016) Calprotectin as a diagnostic tool for inflammatory bowel diseases. Biomedical Reports 5:4, pages 403-407.
Crossref
Crossref
Jeremy R Huddy. (2015) Point-of-care testing in the diagnosis of gastrointestinal cancers: Current technology and future directions. World Journal of Gastroenterology 21:14, pages 4111.
Crossref
Crossref
Timo Gemoll, Rüdiger Meyer & Jens K. Habermann. (2015) Applying Genomics and Proteomics in Translational Surgical Oncology Research. European Surgical Research 55:3, pages 184-197.
Crossref
Crossref
Anjan Dhar. (2015) Faecal calprotectin—ready for prime time?. Frontline Gastroenterology 6:1, pages 11-13.
Crossref
Crossref
Liliana-Elisabeta David, Teodora Surdea-Blaga & Dan-Lucian Dumitrascu. (2014) Semiquantitative fecal calprotectin test in postinfectious and non-postinfectious irritable bowel syndrome: cross-sectional study. Sao Paulo Medical Journal 133:4, pages 343-349.
Crossref
Crossref
Manouchehr Khoshbaten, Parinaz Pishahang, Mohammad Nouri, Alireza Lashkari, Mahasti Alizadeh & Mohammad Rostami-Nejad. (2014) Diagnostic Value of Fecal Calprotectin as a Screening Biomarker for Gastrointestinal Malignancies. Asian Pacific Journal of Cancer Prevention 15:4, pages 1667-1670.
Crossref
Crossref
Aryamitra Banerjee. 2014. Biomarkers in Toxicology. Biomarkers in Toxicology
269
277
.
Annika Winbo, Olof Sandström, Richard Palmqvist & Annika Rydberg. (2012) Iron-deficiency anaemia, gastric hyperplasia, and elevated gastrin levels due to potassium channel dysfunction in the Jervell and Lange-Nielsen Syndrome. Cardiology in the Young 23:3, pages 325-334.
Crossref
Crossref
Emanuel Burri, Michael Manz, Claude Rothen, Livio Rossi, Christoph Beglinger & Frank Serge Lehmann. (2013) Monoclonal antibody testing for fecal calprotectin is superior to polyclonal testing of fecal calprotectin and lactoferrin to identify organic intestinal disease in patients with abdominal discomfort. Clinica Chimica Acta 416, pages 41-47.
Crossref
Crossref
Ingrid Hang, Romy M Heilmann, Niels Grützner, Jan S Suchodolski, Jörg M Steiner, Faik Atroshi, Satu Sankari, Anu Kettunen, Willem M de Vos, Jürgen Zentek & Thomas Spillmann. (2013) Impact of diets with a high content of greaves-meal protein or carbohydrates on faecal characteristics, volatile fatty acids and faecal calprotectin concentrations in healthy dogs. BMC Veterinary Research 9:1, pages 201.
Crossref
Crossref
Michael Manz, Emanuel Burri, Claude Rothen, Nuschin Tchanguizi, Christian Niederberger, Livio Rossi, Christoph Beglinger & Frank Serge Lehmann. (2012) Value of fecal calprotectin in the evaluation of patients with abdominal discomfort: an observational study. BMC Gastroenterology 12:1.
Crossref
Crossref
Ruth M Ayling. (2011) New faecal tests in gastroenterology. Annals of Clinical Biochemistry: International Journal of Laboratory Medicine 49:1, pages 44-54.
Crossref
Crossref
Elin Hestvik, James K Tumwine, Thorkild Tylleskar, Lena Grahnquist, Grace Ndeezi, Deogratias H Kaddu-Mulindwa, Lage Aksnes & Edda Olafsdottir. (2011) Faecal calprotectin concentrations in apparently healthy children aged 0-12 years in urban Kampala, Uganda: a community-based survey. BMC Pediatrics 11:1.
Crossref
Crossref
Murugan Kalimutho, Giovanna Del Vecchio Blanco, Micaela Cretella, Elena Mannisi, Pierpaolo Sileri, Amanda Formosa, Francesco Pallone, Giorgio Federici & Sergio Bernardini. (2011) A simplified, non-invasive fecal-based DNA integrity assay and iFOBT for colorectal cancer detection. International Journal of Colorectal Disease 26:5, pages 583-592.
Crossref
Crossref
Linda J.W. Bosch, Beatriz Carvalho, Remond J.A. Fijneman, Connie R. Jimenez, Herbert M. Pinedo, Manon van Engeland & Gerrit A. Meijer. (2011) Molecular Tests for Colorectal Cancer Screening. Clinical Colorectal Cancer 10:1, pages 8-23.
Crossref
Crossref
Poonam Beniwal & Laura Harrell. (2010) The Status of Diagnostic Markers for Inflammatory Bowel Disease. Current Gastroenterology Reports 12:6, pages 479-484.
Crossref
Crossref
Gianmichele Meucci, Renata D’Incà, Roberto Maieron, Nicoletta Orzes, Maurizio Vecchi, Daniela Visentini, Giorgio Minoli, Elisabetta Dal Pont, Maurizio Zilli, Elvio Benedetti, Tiziana Virgilio & Elio Tonutti. (2010) Diagnostic value of faecal calprotectin in unselected outpatients referred for colonoscopy: A multicenter prospective study. Digestive and Liver Disease 42:3, pages 191-195.
Crossref
Crossref
Cansel Turkay & Benan Kasapoglu. (2010) Noninvasive methods in evaluation of inflammatory bowel disease: where do we stand now? An update. Clinics 65:2, pages 221-231.
Crossref
Crossref
Alain M. Schoepfer, Christoph Beglinger, Alex Straumann, Michael Trummler, Pietro Renzulli & Frank Seibold. (2009) Ulcerative colitis. Inflammatory Bowel Diseases 15:12, pages 1851-1858.
Crossref
Crossref
Hye-Jung Kim, Hyun Ju Kang, Hanna Lee, Seung-Taek Lee, Myeong-Hee Yu, Hoguen Kim & Cheolju Lee. (2009) Identification of S100A8 and S100A9 as Serological Markers for Colorectal Cancer. Journal of Proteome Research 8:3, pages 1368-1379.
Crossref
Crossref
Keishi Yamashita & Masahiko Watanabe. (2009) Clinical significance of tumor markers and an emerging perspective on colorectal cancer. Cancer Science 100:2, pages 195-199.
Crossref
Crossref
J.P. Gisbert & A.G. McNicholl. (2009) Questions and answers on the role of faecal calprotectin as a biological marker in inflammatory bowel disease. Digestive and Liver Disease 41:1, pages 56-66.
Crossref
Crossref
Byong Chul Yoo, Young-Kyoung Shin, Seok-Byung Lim, Sung-Hye Hong, Seung-Yong Jeong & Jae-Gahb Park. (2008) Evaluation of Calgranulin B in Stools from the Patients with Colorectal Cancer. Diseases of the Colon & Rectum 51:11, pages 1703-1709.
Crossref
Crossref
A. Damms & S. C. Bischoff. (2008) Validation and clinical significance of a new calprotectin rapid test for the diagnosis of gastrointestinal diseases. International Journal of Colorectal Disease 23:10, pages 985-992.
Crossref
Crossref
Taina Sipponen, Erkki Savilahti, Päivi Kärkkäinen, Kaija-Leena Kolho, Hannu Nuutinen, Ulla Turunen & Martti Färkkilä. (2008) Fecal calprotectin, lactoferrin, and endoscopic disease activity in monitoring anti-TNF-alpha therapy for Crohnʼs disease. Inflammatory Bowel Diseases 14:10, pages 1392-1398.
Crossref
Crossref
Romy M. Heilmann, Jan S. Suchodolski & Jörg M. Steiner. (2008) Development and analytic validation of a radioimmunoassay for the quantification of canine calprotectin in serum and feces from dogs. American Journal of Veterinary Research 69:7, pages 845-853.
Crossref
Crossref
Dorota Walkiewicz, Steven L. Werlin, Daryl Fish, Mathew Scanlon, Patrick Hanaway & Subra Kugathasan. (2008) Fecal calprotectin is useful in predicting disease relapse in pediatric inflammatory bowel disease. Inflammatory Bowel Diseases 14:5, pages 669-673.
Crossref
Crossref
Marc A. Sidler, Steven T. Leach & Andrew S. Day. (2008) Fecal S100A12 and fecal calprotectin as noninvasive markers for inflammatory bowel disease in children. Inflammatory Bowel Diseases 14:3, pages 359-366.
Crossref
Crossref
Jun-Ying Xiang, Qin Ouyang, Guo-Dong Li & Nan-Ping Xiao. (2008) Clinical value of fecal calprotectin in determining disease activity of ulcerative colitis. World Journal of Gastroenterology 14:1, pages 53.
Crossref
Crossref
Jürgen Stein, Stefan M. Loitsch & Yogesh Shastri. (2008) Non-invasive detection of colorectal cancer – do we still need the guaiac-based fecal occult blood test? 1. LaboratoriumsMedizin 32:3, pages -.
Crossref
Crossref
Jürgen Stein, Stefan M. Loitsch & Yogesh Shastri. (2008) Nicht-invasive Diagnostik kolorektaler Tumore – Hat der Guaiac-Test ausgedient? / Non-invasive detection of colorectal cancer – do we still need the guaiac-based fecal occult blood test?. LaboratoriumsMedizin 32:3, pages 158-167.
Crossref
Crossref
Taina Sipponen, Erkki Savilahti, Kaija-Leena Kolho, Hannu Nuutinen, Ulla Turunen & Martti Färkkilä. (2008) Crohnʼs disease activity assessed by fecal calprotectin and lactoferrin: Correlation with Crohnʼs disease activity index and endoscopic findings. Inflammatory Bowel Diseases 14:1, pages 40-46.
Crossref
Crossref
Ariella Bar-Gil Shitrit, Dan Braverman, Halina Stankiewics, David Shitrit, Nir Peled & Kalman Paz. (2007) Fecal Calprotectin as a Predictor of Abnormal Colonic Histology. Diseases of the Colon & Rectum 50:12, pages 2188-2193.
Crossref
Crossref
Jens K. Habermann, Franz G. Bader, Christian Franke, Kaja Zimmermann, Timo Gemoll, Britta Fritzsche, Thomas Ried, Gert Auer, Hans-Peter Bruch & Uwe J. Roblick. (2007) From the genome to the proteome—biomarkers in colorectal cancer. Langenbeck's Archives of Surgery 393:1, pages 93-104.
Crossref
Crossref
Reza Yousefi, Mehdi Imani, Susan K. Ardestani, Ali Akbar Saboury, Nematollah Gheibi & Bijan Ranjbar. (2007) Human Calprotectin: Effect of Calcium and Zinc on its Secondary and Tertiary Structures, and Role of pH in its Thermal Stability. Acta Biochimica et Biophysica Sinica 39:10, pages 795-802.
Crossref
Crossref
Charles L. Bevins. 2007. Ciba Foundation Symposium 186 - Antimicrobial Peptides. Ciba Foundation Symposium 186 - Antimicrobial Peptides
250
269
.
Raffaele Pezzilli, Alessandra Barassi, Antonio M. Morselli-Labate, Lorenzo Fantini, Paola Tomassetti, Davide Campana, Riccardo Casadei, Sergio Finazzi, Gianvico Melzi d'Eril & Roberto Corinaldesi. (2007) Fecal calprotectin and elastase 1 determinations in patients with pancreatic diseases: a possible link between pancreatic insufficiency and intestinal inflammation. Journal of Gastroenterology 42:9, pages 754-760.
Crossref
Crossref
Alexander C. von Roon, Leonidas Karamountzos, Sanjay Purkayastha, George E. Reese, Ara W. Darzi, Julian P. Teare, Paraskevas Paraskeva & Paris P. Tekkis. (2007) Diagnostic Precision of Fecal Calprotectin for Inflammatory Bowel Disease and Colorectal Malignancy. The American Journal of Gastroenterology 102:4, pages 803-813.
Crossref
Crossref
Renata D’Incà, Elisabetta Dal Pont, Vincenza Di Leo, Antonio Ferronato, Walter Fries, Maria Grazia Vettorato, Diego Martines & Giacomo Carlo Sturniolo. (2006) Calprotectin and lactoferrin in the assessment of intestinal inflammation and organic disease. International Journal of Colorectal Disease 22:4, pages 429-437.
Crossref
Crossref
Yogesh M. Shastri, Marc Naumann, Gerhard M. Oremek, Ernst Hanisch, Wolfgang Rösch, Joachim Mössner, Wolfgang F. Caspary & Jürgen M. Stein. (2006) Prospective multicenter evaluation of fecal tumor pyruvate kinase type M2 (M2-PK) as a screening biomarker for colorectal neoplasia. International Journal of Cancer 119:11, pages 2651-2656.
Crossref
Crossref
Naomi S.H. de Jong, Steven T. Leach & Andrew S. Day. (2006) Fecal S100A12: A novel noninvasive marker in children with Crohnʼs disease. Inflammatory Bowel Diseases 12:7, pages 566-572.
Crossref
Crossref
María del Valle García Sánchez, Raúl González, Eva Iglesias Flores, Federico Gómez Camacho, Luis Casais Juanena, Antonio Cerezo Ruiz, Manuel Montero Pérez-Barquero, Jordi Muntané & Juan Francisco de Dios Vega. (2006) Precisión diagnóstica de la calprotectina fecal para predecir una colonoscopia patológica. Medicina Clínica 127:2, pages 41-46.
Crossref
Crossref
Njaal Stray & Ragnar Weberg. (2006) A prospective study of same day bi-directional endoscopy in the evaluation of patients with occult gastrointestinal bleeding. Scandinavian Journal of Gastroenterology, pages 1-1.
Crossref
Crossref
Ulrike Haug & Hermann Brenner. (2005) New stool tests for colorectal cancer screening: A systematic review focusing on performance characteristics and practicalness. International Journal of Cancer 117:2, pages 169-176.
Crossref
Crossref
D.R. Gaya, T.D.B. Lyon, A. Duncan, J.B. Neilly, S. Han, J. Howell, C. Liddell, A.J. Stanley, A.J. Morris & J.F. Mackenzie. (2005) Faecal calprotectin in the assessment of Crohn's disease activity. QJM: An International Journal of Medicine 98:6, pages 435-441.
Crossref
Crossref
Ulrika Lorentzon Fagerberg, Lars L????f, Urban Myrdal, Lars-Olof Hansson & Yigael Finkel. (2005) Colorectal Inflammation is Well Predicted by Fecal Calprotectin in Children with Gastrointestinal Symptoms. Journal of Pediatric Gastroenterology and Nutrition 40:4, pages 450-455.
Crossref
Crossref
I. Bjarnason, L. Maiden & K. Takeuchi. 2005. Gastroenterology Yesterday — Today — Tomorrow: A Review and Preview. Gastroenterology Yesterday — Today — Tomorrow: A Review and Preview
253
266
.
E. Bruzzese, V. Raia, G. Gaudiello, G. Polito, V. Buccigrossi, V. Formicola & A. Guarino. (2004) Intestinal inflammation is a frequent feature of cystic fibrosis and is reduced by probiotic administration. Alimentary Pharmacology & Therapeutics 20:7, pages 813-819.
Crossref
Crossref
T Mak, F Lalloo, D G R Evans & J Hill. (2004) Molecular stool screening for colorectal cancer. British Journal of Surgery 91:7, pages 790-800.
Crossref
Crossref
Andrew Poullis, Russell Foster, Ajeya Shetty, Magne K. Fagerhol & Michael A. Mendall. (2004) Bowel Inflammation as Measured by Fecal Calprotectin. Cancer Epidemiology, Biomarkers & Prevention 13:2, pages 279-284.
Crossref
Crossref
Paul J Limburg, Mary E Devens, Jonathan J Harrington, Nancy N Diehl, Douglas W Mahoney & David A Ahlquist. (2003) Prospective Evaluation of Fecal Calprotectin As A Screening Biomarker for Colorectal Neoplasia. American Journal of Gastroenterology 98:10, pages 2299-2305.
Crossref
Crossref
Ulrika Lorentzon Fagerberg, Lars Lööf, Rumjana Djilali Merzoug, Lars-Olof Hansson & Yigael Finkel. (2003) Fecal Calprotectin Levels in Healthy Children Studied With an Improved Assay. Journal of Pediatric Gastroenterology and Nutrition 37:4, pages 468-472.
Crossref
Crossref
F Costa, M.G Mumolo, M Bellini, M.R Romano, L Ceccarelli, P Arpe, C Sterpi, S Marchi & G Maltinti. (2003) Role of faecal calprotectin as non-invasive marker of intestinal inflammation. Digestive and Liver Disease 35:9, pages 642-647.
Crossref
Crossref
A.G Røseth. (2003) Determination of faecal calprotectin, a novel marker of organic gastrointestinal disorders. Digestive and Liver Disease 35:9, pages 607-609.
Crossref
Crossref
ANDREW POULLIS, RUSSELL FOSTER, MICHAEL A MENDALL & MAGNE K FAGERHOL. (2003) Emerging role of calprotectin in gastroenterology. Journal of Gastroenterology and Hepatology 18:7, pages 756-762.
Crossref
Crossref
Antonio Carroccio, Giuseppe Iacono, Mario Cottone, Lidia Di Prima, Fabio Cartabellotta, Francesca Cavataio, Calogero Scalici, Giuseppe Montalto, Gaetana Di Fede, GiovamBattista Rini, Alberto Notarbartolo & Maurizio R Averna. (2003) Diagnostic Accuracy of Fecal Calprotectin Assay in Distinguishing Organic Causes of Chronic Diarrhea from Irritable Bowel Syndrome: A Prospective Study in Adults and Children. Clinical Chemistry 49:6, pages 861-867.
Crossref
Crossref
Christopher B. Summerton, Michael G. Longlands, Keith Wiener & David R. Shreeve. (2002) Faecal calprotectin: a marker of inflammation throughout the intestinal tract. European Journal of Gastroenterology & Hepatology 14:8, pages 841-845.
Crossref
Crossref
E Olafsdottir, L Aksnes, G Fluge & A Berstad. (2007) Faecal calprotectin levels in infants with infantile colic, healthy infants, children with inflammatory bowel disease, children with recurrent abdominal pain and healthy children. Acta Paediatrica 91:1, pages 45-50.
Crossref
Crossref
Einar Husebye, Hege Ton & Berit Johne. (2001) Biological variability of fecal calprotectin in patients referred for colonoscopy without colonic inflammation or neoplasm1. The American Journal of Gastroenterology 96:9, pages 2683-2687.
Crossref
Crossref
Susan K. Bunn, W. Michael Bisset, Margaret J. C. Main, Elizabeth S. Gray, Shona Olson & Barbara E. Golden. (2001) Fecal Calprotectin: Validation as a Noninvasive Measure of Bowel Inflammation in Childhood Inflammatory Bowel Disease. Journal of Pediatric Gastroenterology and Nutrition 33:1, pages 14-22.
Crossref
Crossref
Susan K. Bunn, W. Michael Bisset, Margaret J.C. Main & Barbara E. Golden. (2001) Fecal Calprotectin as a Measure of Disease Activity in Childhood Inflammatory Bowel Disease. Journal of Pediatric Gastroenterology and Nutrition 32:2, pages 171-177.
Crossref
Crossref
JA Tibble. (2001) Non-invasive investigation of inflammatory bowel disease. World Journal of Gastroenterology 7:4, pages 460.
Crossref
Crossref
Magne K Fagerhol. (2000) Calprotectin, a faecal marker of organic gastrointestinal abnormality. The Lancet 356:9244, pages 1783-1784.
Crossref
Crossref
Szabolcs Ott� & S�ndor Eckhardt. (2000) Early detection for colorectal cancer: New aspects in fecal occult blood screening. Journal of Surgical Oncology 75:3, pages 220-226.
Crossref
Crossref
Hege Tøn, Øystein Brandsnes, Siri Dale, Jostein Holtlund, Eugenia Skuibina, Henning Schjønsby & Berit Johne. (2000) Improved assay for fecal calprotectin. Clinica Chimica Acta 292:1-2, pages 41-54.
Crossref
Crossref
Paul Thomas, Hanan Rihani, Arne Røseth, Gudmundur Sigthorsson, Ashley Price, R. John Nicholls & Ingvar Bjarnason. (2000) Assessment of ileal pouch inflammation by single-stool calprotectin assay. Diseases of the Colon & Rectum 43:2, pages 214-220.
Crossref
Crossref
David A. Ahlquist, Jonathan J. Harrington, Lawrence J. Burgart & Patrick C. Roche. (2000) Morphometric analysis of the “mucocellular layer” overlying colorectal cancer and normal mucosa: Relevance to exfoliation and stool screening. Human Pathology 31:1, pages 51-57.
Crossref
Crossref
Junru Wang, Huaien Zheng, Ching-Ching Sung & Martin Hauer-Jensen. (1999) The synthetic somatostatin analogue, octreotide, ameliorates acute and delayed intestinal radiation injury. International Journal of Radiation Oncology*Biology*Physics 45:5, pages 1289-1296.
Crossref
Crossref
Jon Kristinsson, Arne Røseth, Magne Kr. Fagerhol, Erling Aadland, Henning Schjønsby, Ole P. Børmer, Nils Raknerud & Knut Nygaard. (1998) Fecal calprotectin concentration in patients with colorectal carcinoma. Diseases of the Colon & Rectum 41:3, pages 316-321.
Crossref
Crossref
J. Kido, S. Nishikawa, H. Ishida, K. Yamashita, S. Kitamura, K. Kohri & T. Nagata. (2006) Identification of calprotectin, a calcium binding leukocyte protein, in human dental calculus matrix. Journal of Periodontal Research 32:4, pages 355-361.
Crossref
Crossref
K.K. Richter, M.K. Fagerhol, J.C. Carr, J.M. Winkler, C.C. Sung & M. Hauer-Jensen. (1997) Association of granulocyte transmigration with structural and cellular parameters of injury in experimental radiation enteropathy. Radiation Oncology Investigations 5:6, pages 275-282.
Crossref
Crossref